| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 17, 2004
From the Pulmonary, Critical Care and Sleep Division, Tufts-New England Medical Center, Tupper Research Institute (I.R.P., N.S.H., Y.J.S.), and Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University (G.T., J.U.T., Y.J.S.), Boston, Mass; and Department of Pharmacology, Georgetown University Medical Center, Washington, DC (Y.J.S.). * To whom correspondence should be addressed. E-mail: ys82{at}georgetown.edu.
Background--Retinoic acid has antimitogenic effects on smooth muscle cells. Studies on the systemic circulation suggest that it may reduce vascular thickening. Relationships between retinoids and pulmonary hypertension/pulmonary vascular remodeling, however, have not been explored. Thus, the present study examined retinoid levels in plasma of patients with idiopathic pulmonary arterial hypertension and the effects of retinoic acid on human pulmonary artery smooth muscle cell growth. Methods and Results--We measured retinoid levels by gas chromatograph-mass spectrometer technique in plasma of idiopathic pulmonary arterial hypertension patients and in age- and sex-matched healthy control subjects. Patients had significantly lower levels of all-trans retinoic acid and 13-cis retinoic acid than control subjects but similar 9-cis retinoic acid and retinol levels. In cultured human pulmonary artery smooth muscle cells, all-trans retinoic acid suppressed serotonin-induced cell growth. These cells were found to express the retinoid acid receptors RAR Conclusions--Idiopathic pulmonary arterial hypertension patients have reduced retinoic acid levels, and retinoic acid treatment can elicit growth-inhibitory signals in pulmonary artery smooth muscle cells in vitro. Thus, retinoic acid may influence pulmonary vascular remodeling in humans.
Revised on October 2, 2004
Accepted on November 4, 2004
Retinoids and Pulmonary Hypertension
Ioana R. Preston MD,
, RAR
, RAR
, RXR
, and RXR
. Gene array analysis showed that retinoic acid induces the expression of GADD45A, a known cell growth suppressor. Contrary to expectations, plasma from pulmonary hypertension patients suppressed cell growth, likely influenced by factors other than retinoids.
This article has been cited by other articles:
![]() |
K. E. Roberts, M. B. Fallon, M. J. Krowka, R. S. Brown, J. F. Trotter, I. Peter, H. Tighiouart, J. A. Knowles, D. Rabinowitz, R. L. Benza, et al. Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease Am. J. Respir. Crit. Care Med., May 1, 2009; 179(9): 835 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ocaya, A. C. Gidlof, P. S. Olofsson, H. Torma, and A. Sirsjo CYP26 Inhibitor R115866 Increases Retinoid Signaling in Intimal Smooth Muscle Cells Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1542 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Day, Y. H. Lee, A.-M. Park, and Y. J. Suzuki Retinoic Acid Inhibits Airway Smooth Muscle Cell Migration Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 695 - 703. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |